Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 29, 2022
Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence
David Dum, Tjark L C Henke, Tim Mandelkow, et al.
Scientific Reports
|
August 9, 2023
Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid
Maximilian Lennartz, Henrietta Csomós, Viktoria Chirico, et al.
Plos One
|
June 28, 2023
CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas
Ria Uhlig, Nina Bröker, Sören Weidemann, et al.
Virchows Archiv : an International Journal of Pathology
|
June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors
Viktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.
Diagnostics (Basel, Switzerland)
|
August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype
Viktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.
BMC Urology
|
April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors
Henning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Biomarker Research
|
December 10, 2024
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples
Seyma Büyücek, Nina Schraps, Anne Menz, et al.
Diagnostic Pathology
|
January 13, 2024
Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities
Florian Viehweger, Carola Böcker, Sören Weidemann, et al.
The American Journal of Surgical Pathology
|
August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor Types
Natalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
Plos One
|
April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors
Seyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 29, 2022
Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence
David Dum, Tjark L C Henke, Tim Mandelkow, et al.
Scientific Reports
|
August 9, 2023
Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid
Maximilian Lennartz, Henrietta Csomós, Viktoria Chirico, et al.
Plos One
|
June 28, 2023
CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas
Ria Uhlig, Nina Bröker, Sören Weidemann, et al.
Virchows Archiv : an International Journal of Pathology
|
June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors
Viktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.
Diagnostics (Basel, Switzerland)
|
August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype
Viktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.
BMC Urology
|
April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors
Henning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Biomarker Research
|
December 10, 2024
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples
Seyma Büyücek, Nina Schraps, Anne Menz, et al.
Diagnostic Pathology
|
January 13, 2024
Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities
Florian Viehweger, Carola Böcker, Sören Weidemann, et al.
The American Journal of Surgical Pathology
|
August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor Types
Natalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
Plos One
|
April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors
Seyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Page
of 12